Laetitia has more than two decades of diverse experience spanning various industries, with a commendable 17 years dedicated to the pharmaceutical and medical device sector. Her expertise extends to steering and overseeing intricate multi-jurisdictional operations, including global multimillion-dollar M&A transactions, licensing agreements, and collaborative partnerships.
Since December 2023, Laetitia manages the global legal and compliance functions, preparing the organization for launch in Europe and the US. She is also heading the enterprise risk management and ESG function across international markets at Egetis Therapeutics.
Prior to this, she played a pivotal role in the Legal operations and Corporate Development at AM-Pharma, preparing for the company’s IPO readiness and commercialization. Her professional journey also includes UCB as the global Associate General Counsel for BD, M&A, and Antitrust. Her outstanding performance earned her recognition as Top Talent with three awards. She represented AM-Pharma and UCB at EFPIA in Brussels, actively contributing to EU policymaking.
Laetitia also serve at Zoetis (formerly Pfizer’s animal health division), and at At Abbott Vascular. Beyond the healthcare realm, she held notable global positions at the Carlson Rezidor Hotel Group and in the automotive division (Wabco) at American Standard, where she led negotiations on global multi-million outsourcing deals and restructured the entire EU distribution system.
Laetitia holds qualifications as a lawyer in both the UK and Belgium, showcasing her extensive international experience. Renowned for her insights, she is a regular speaker at various legal conferences, contributing her wealth of knowledge and expertise to the legal community.